KURA - Kura Oncology, Inc.

QQQ $ 602.34 $ -5.20 (-0.85 %)

DIA $ 466.18 $ -5.48 (-1.16 %)

SPY $ 664.83 $ -6.26 (-0.93 %)

TLT $ 89.11 $ 0.22 (0.25 %)

GLD $ 370.86 $ -4.31 (-1.15 %)

Previous Close

$ 10.85

Open

$ 11.16

Bid

$ 10.80 x 83

Ask

$ 10.83 x 1

Day's Range

$ 10.79 - $ 11.48

52 Week Range

$ 5.41 - $ 16.68

Volume

2,724,076

Average Volume

Market Cap

944.14M

Beta (5Y Monthly)

$ 1.24

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-01-2025	03-31-2025	10-Q
4	02-28-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	02-27-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-09-2023	06-30-2023	10-Q
11	05-10-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-04-2020	03-31-2020	10-Q
24	02-25-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	08-01-2019	06-30-2019	10-Q
27	05-07-2019	03-31-2019	10-Q
28	03-05-2019	12-31-2018	10-K
29	11-05-2018	09-30-2018	10-Q
30	08-06-2018	06-30-2018	10-Q
31	05-08-2018	03-31-2018	10-Q
32	03-12-2018	12-31-2017	10-K
33	11-07-2017	09-30-2017	10-Q
34	08-07-2017	06-30-2017	10-Q
35	05-15-2017	03-31-2017	10-Q
36	03-14-2017	12-31-2016	10-K
37	11-07-2016	09-30-2016	10-Q
38	08-10-2016	06-30-2016	10-Q
39	05-11-2016	03-31-2016	10-Q
40	03-17-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

kura-scores-a-big-win-as-fda-approves-its-new-leukemia-pill

Kura Scores A Big Win As FDA Approves Its ...
11/14/2025 17:43:58

Komzifti wins full FDA approval for NPM1-mutated AML, supported by KOMET-001 data, as Wedbush boosts Kura Oncology's price ...

UBS Maintains Buy on Kura Oncology, Raises...
11/14/2025 17:13:45

UBS analyst David Dai maintains Kura Oncology (NASDAQ:KURA) with a Buy and raises the price target from $14 to $16.

Wedbush Maintains Outperform on Kura Oncol...
11/14/2025 15:15:58

Wedbush analyst Robert Driscoll maintains Kura Oncology (NASDAQ:KURA) with a Outperform and raises the price target from $36...

Kura Oncology Exec Says: Already In Dialog...
11/13/2025 18:07:08

- Conf Call

Trading Halt: Halt status updated at 11:25...
11/13/2025 16:25:04

$fda-approves-ziftomenib-for-relapsed-or-refractory-acute-myeloid-leukemia-with-a-npm1-mutation$

FDA Approves Ziftomenib For Relapsed Or Re...
11/13/2025 15:15:44

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ziftomenib-relapsed-or-refractory-acute-myeloid-leu...

Trading Halt: Halted at 9:59:53 a.m. ET - ...
11/13/2025 14:59:57

Kura Oncology Q3 EPS $(0.85) Misses $(0.84...
11/04/2025 11:34:40

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.8...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

Kura Oncology Gets $30M Milestone Payment ...
11/03/2025 21:11:04

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision ...

Kura Oncology To Feature Results From KOME...
11/03/2025 14:25:08

– Data to be featured in two oral presentations on December 8, 2025 –– Broad development program assesses ziftomenib across div...

kura-oncology-scores-30-million-boost-as-new-leukemia-drug-enters-major-trial

Kura Oncology Scores $30 Million Boost As ...
10/24/2025 16:17:11

Kura Oncology rises after $30M milestone from Kyowa Kirin; Phase 3 ziftomenib dosing and FTI data at ESMO bolster pipeline.

Kura Oncology Receives $30M Development Mi...
10/24/2025 11:03:24

JMP Securities Reiterates Market Outperfor...
10/20/2025 13:37:22

JMP Securities analyst Reni J. Benjamin reiterates Kura Oncology (NASDAQ:KURA) with a Market Outperform and maintains $24 pr...

HC Wainwright & Co. Reiterates Buy on Kura...
10/20/2025 11:49:25

HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $40 price t...

Reported Saturday, Kura Oncology Presents ...
10/20/2025 08:19:09

FTI mechanism addresses innate and adaptive resistance pathways common to targeted oncology therapiesEarly clinical and preclin...

Kura Oncology And Kyowa Kirin Announce Dos...
10/01/2025 11:11:48

– Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhib...

HC Wainwright & Co. Reiterates Buy on Kura...
09/30/2025 10:54:42

HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $40 price t...

Kura Oncology And Kyowa Kirin Dose First P...
09/29/2025 20:01:50

10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...